Dr Reddys Laboratories (RDY) Gross Margin (2012 - 2026)

Dr Reddys Laboratories' Gross Margin history runs 15 years deep, the most recent figure standing at 38.26% for Q1 2026.

• In Q1 2026, Gross Margin fell 1730.0% year-over-year to 38.26%; the TTM figure through Mar 2026 stood at 51.18% (down 735.0% YoY), while the FY2026 annual figure was 52.77%, down 575.0% from the prior year.
• Gross Margin was 38.26% for Q1 2026 at Dr Reddys Laboratories, down from 53.63% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 60.4% in Q2 2024 to a low of 0.0% in Q3 2022.
• Historically, Gross Margin has averaged 52.65% across 5 years, with a median of 58.53% in 2024.
• The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 5378 bps in 2022, then surged 5867 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 57.24% in 2022, then rose by 2 bps to 58.5% in 2023, then grew by 0 bps to 58.68% in 2024, then declined by 9 bps to 53.63% in 2025, then decreased by 29 bps to 38.26% in 2026.
• The last three Gross Margin figures came in at 38.26% (Q1 2026), 53.63% (Q4 2025), and 56.91% (Q2 2025), per Business Quant data.